Related Experiment Video
Updated: Apr 14, 2026

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
Published on: December 19, 2025
Graphene as cancer theranostic tool: progress and future challenges
Marco Orecchioni1, Roberto Cabizza1, Alberto Bianco2
11. Department of Chemistry and Pharmacy, University of Sassari , via muroni 23 07100 Sassari, Italy.
Abstract:
Nowadays cancer remains one of the main causes of death in the world. Current diagnostic techniques need to be improved to provide earlier diagnosis and treatment. Traditional therapy approaches to cancer are limited by lack of specificity and systemic toxicity. In this scenario nanomaterials could be good allies to give more specific cancer treatment effectively reducing undesired side effects and giving at the same time accurate diagnosis and successful therapy. In this context, thanks to its unique physical and chemical properties, graphene, graphene oxide (GO) and reduced graphene (rGO) have recently attracted tremendous interest in biomedicine including cancer therapy. Herein we analyzed all studies presented in literature related to cancer fight using graphene and graphene-based conjugates. In this context, we aimed at the full picture of the state of the art providing new inputs for future strategies in the cancer theranostic by using of graphene. We found an impressive increasing interest in the material for cancer therapy and/or diagnosis. The majority of the works (73%) have been carried out on drug and gene delivery applications, following by photothermal therapy (32%), imaging (31%) and photodynamic therapy (10%). A 27% of the studies focused on theranostic applications. Part of the works here discussed contribute to the growth of the theranostic field covering the use of imaging (i.e. ultrasonography, positron electron tomography, and fluorescent imaging) combined to one or more therapeutic modalities. We found that the use of graphene in cancer theranostics is still in an early but rapidly growing stage of investigation. Any technology based on nanomaterials can significantly enhance their possibility to became the real revolution in medicine if combines diagnosis and therapy at the same time. We performed a comprehensive summary of the latest progress of graphene cancer fight and highlighted the future challenges and the innovative possible theranostic applications.
Insights
Graphene and its derivatives show promise for advanced cancer theranostics, combining diagnosis and therapy. Research indicates significant growth in graphene-based drug delivery, photothermal therapy, and imaging for improved cancer treatment.
Area of Science:
- Biomedical Engineering
- Materials Science
- Oncology
Background:
- Cancer remains a leading global cause of death, necessitating improved diagnostic and therapeutic strategies.
- Traditional cancer treatments face limitations due to lack of specificity and systemic toxicity.
- Nanomaterials offer potential for targeted cancer therapy with reduced side effects and integrated diagnosis.
Purpose of the Study:
- To comprehensively review literature on graphene and its derivatives (graphene oxide, reduced graphene oxide) for cancer therapy and diagnosis.
- To analyze the current state-of-the-art in graphene-based cancer theranostics.
- To identify future challenges and innovative applications of graphene in oncology.
Main Methods:
- Systematic literature review of studies utilizing graphene-based materials for cancer treatment and diagnosis.
- Analysis of application trends, including drug/gene delivery, photothermal therapy, imaging, and theranostics.
- Categorization of research based on combined diagnostic and therapeutic modalities.
Main Results:
- Significant and increasing research interest in graphene for cancer applications.
- Dominant applications include drug/gene delivery (73%), photothermal therapy (32%), and imaging (31%).
- Theranostic applications, combining imaging and therapy, are a growing area (27%).
Conclusions:
- Graphene-based cancer theranostics are in an early but rapidly advancing stage.
- The integration of diagnosis and therapy using nanomaterials like graphene holds revolutionary potential for medicine.
- Further research is needed to overcome challenges and realize the full potential of graphene in personalized cancer care.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

